设计一种瘤选择性前药,T细胞引入双特异抗体,以实现更安全的免疫疗法
Amelia C McCue1, Stephen J Demarest2, Karen J Froning2
1Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.
mAbs
|July 4, 2024
概括
研究人员设计了一种更安全的T细胞参与 (TCE) 双特异抗体前体药物. 这种蒙面抗体特别在瘤部位激活,减少有毒副作用并增强癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 结构生物学 结构生物学
背景情况:
- 参与T细胞 (TCE) 双特异性抗体利用免疫系统对抗癌症.
- 目前的TCE面临的局限性是由于剂量限制性毒性,来自于点,瘤外的作用.
- 掩盖TCEs在瘤微环境中激活提供了一种提高安全性的策略.
研究的目的:
- 为了设计一种TCE双特异抗体的蛋白酶激活前药物形式.
- 增强瘤选择性T细胞活性,降低全身毒性.
- 为了证明这种掩盖策略在TCE开发中的广泛适用性.
主要方法:
- 解决了新型抗CD3抗体片段 (E10) 和其表位的晶体结构.
- 通过矩阵金属蛋白酶2 (MMP-2) 激活的蒙面E10 TCE原药.
- 评估了前药物的结合,体外T细胞激活和杀死试验.
主要成果:
- 设计的前药TCE在体外证明了MMP-2-依赖的,瘤选择性的T细胞激活和杀死.
- 掩蔽策略成功地应用于不同的抗CD3抗体 (SP34).
- 结构洞察力指导了对蛋白酶敏感的掩盖图案的工程.
结论:
- 蛋白酶激活的TCE预药是一种有前途的方法,可以提高癌症免疫疗法的安全性.
- 这一策略有可能扩大TCE双特异抗体的治疗窗口.
- 蒙面TCE的进一步开发可能会导致更安全,更有效的癌症治疗.
关键词:
抗体工程是一种抗体工程.CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD4 CD4 CD4 CD4 CD4 CD4 CD5 CD5 CD5 CD5 CD6 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7在HER2中,HER2是HER2.在T细胞激活过程中,在T细胞重定位的过程中.两种特异性抗体的抗体癌症 癌症 癌症 癌症 癌症细胞因子释放综合征 细胞因子释放综合征在X射线图中,X射线结构是什么?
相关概念视频
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K